Distinct loiasis infection states and associated clinical and hematological manifestations in patients from Gabon.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
23
05
2022
accepted:
06
09
2022
revised:
29
09
2022
pubmed:
20
9
2022
medline:
4
10
2022
entrez:
19
9
2022
Statut:
epublish
Résumé
Loiasis-a filarial disease endemic in Central and West Africa-is increasingly recognized as significant individual and public health concern. While the understanding of the disease characteristics remains limited, significant morbidity and excess mortality have been demonstrated. Here, we characterize clinical and hematological findings in a large cohort from Gabon. Loiasis-related clinical manifestations and microfilaremia, hemoglobin and differential blood counts were recorded prospectively during a cross-sectional survey. For analysis, participants were categorized into distinct infection states by the diagnostic criteria of eye worm history and microfilaremia. Analysis of data from 1,232 individuals showed that occurrence of clinical and hematological findings differed significantly between the infection states. Eye worm positivity was associated with a wide range of clinical manifestations while microfilaremia by itself was not. Loa loa infection was associated with presence of eosinophilia and absolute eosinophil counts were associated with extent of microfilaremia (p-adj. = 0.012, ß-estimate:0.17[0.04-0.31]). Loiasis is a complex disease, causing different disease manifestations in patients from endemic regions. The consequences for the affected individuals or populations as well as the pathophysiological consequences of correlating eosinophilia are largely unknown. High-quality research on loiasis should be fostered to improve patient care and understanding of the disease.
Sections du résumé
BACKGROUND
Loiasis-a filarial disease endemic in Central and West Africa-is increasingly recognized as significant individual and public health concern. While the understanding of the disease characteristics remains limited, significant morbidity and excess mortality have been demonstrated. Here, we characterize clinical and hematological findings in a large cohort from Gabon.
METHODS
Loiasis-related clinical manifestations and microfilaremia, hemoglobin and differential blood counts were recorded prospectively during a cross-sectional survey. For analysis, participants were categorized into distinct infection states by the diagnostic criteria of eye worm history and microfilaremia.
RESULTS
Analysis of data from 1,232 individuals showed that occurrence of clinical and hematological findings differed significantly between the infection states. Eye worm positivity was associated with a wide range of clinical manifestations while microfilaremia by itself was not. Loa loa infection was associated with presence of eosinophilia and absolute eosinophil counts were associated with extent of microfilaremia (p-adj. = 0.012, ß-estimate:0.17[0.04-0.31]).
CONCLUSIONS
Loiasis is a complex disease, causing different disease manifestations in patients from endemic regions. The consequences for the affected individuals or populations as well as the pathophysiological consequences of correlating eosinophilia are largely unknown. High-quality research on loiasis should be fostered to improve patient care and understanding of the disease.
Identifiants
pubmed: 36121900
doi: 10.1371/journal.pntd.0010793
pii: PNTD-D-22-00669
pmc: PMC9521832
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010793Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Open Forum Infect Dis. 2019 Nov 01;6(11):ofz417
pubmed: 31696139
Am J Trop Med Hyg. 1999 Apr;60(4):680-6
pubmed: 10348248
Res Rep Trop Med. 2018 Apr 03;9:43-48
pubmed: 30050354
Lancet Infect Dis. 2022 Jul;22(7):e197-e206
pubmed: 35219405
Ann Trop Med Parasitol. 2007 Mar;101(2):151-60
pubmed: 17316501
J Infect Dis. 1991 Jun;163(6):1318-25
pubmed: 2037798
Lancet Infect Dis. 2020 Nov;20(11):1339-1346
pubmed: 32585133
J Infect Dis. 1986 Jul;154(1):10-8
pubmed: 3458832
Trends Parasitol. 2018 Apr;34(4):335-350
pubmed: 29331268
J Helminthol. 2016 Jul;90(4):469-75
pubmed: 26268068
Am J Trop Med Hyg. 2002 Mar;66(3):245-50
pubmed: 12139215
Lancet Infect Dis. 2022 Oct;22(10):e299-e302
pubmed: 35500592
Bull World Health Organ. 2002;80(11):852-8
pubmed: 12481206
Parasitol Today. 1988 Oct;4(10):279-84
pubmed: 15463001
J Infect Dis. 2021 Feb 3;223(2):287-296
pubmed: 33099649
Trans R Soc Trop Med Hyg. 1987;81(3):441-6
pubmed: 3479854
Am J Trop Med Hyg. 2021 Sep 13;105(6):1448-1449
pubmed: 34516401
Am J Trop Med Hyg. 2011 May;84(5):733-7
pubmed: 21540382
Ann Trop Med Parasitol. 2006 Dec;100(8):715-31
pubmed: 17227650
Blood. 2004 Jun 1;103(11):4050-5
pubmed: 14988154
Lancet Infect Dis. 2014 Apr;14(4):353-7
pubmed: 24332895
Handb Clin Neurol. 2013;114:235-42
pubmed: 23829914
Ann Trop Med Parasitol. 2005 Jul;99(5):491-500
pubmed: 16004708
Clin Infect Dis. 2015 Jan 1;60(1):55-63
pubmed: 25234520
J Allergy Clin Immunol. 2004 Jan;113(1):30-7
pubmed: 14713904
Am J Trop Med Hyg. 1989 Sep;41(3):331-7
pubmed: 2679158
J Glob Health. 2018 Jun;8(1):010413
pubmed: 29497506
PLoS Negl Trop Dis. 2008 Apr 30;2(4):e217
pubmed: 18446236
Clin Infect Dis. 2018 Feb 10;66(5):751-757
pubmed: 29040446
Ann Trop Med Parasitol. 2010 Sep;104(6):455-64
pubmed: 20863434
Trans R Soc Trop Med Hyg. 1988;82(5):730
pubmed: 3252591
Clin Infect Dis. 2021 Mar 1;72(5):789-796
pubmed: 32055862
Lancet Infect Dis. 2017 Jan;17(1):108-116
pubmed: 27777031
PLoS Negl Trop Dis. 2011 Oct;5(10):e1329
pubmed: 22022623
PLoS Negl Trop Dis. 2011 Aug;5(8):e1299
pubmed: 21912716
Acta Trop. 1998 May;69(2):127-40
pubmed: 9588233
PLoS Negl Trop Dis. 2011 Jun;5(6):e1210
pubmed: 21738809
PLoS Negl Trop Dis. 2012;6(5):e1655
pubmed: 22666510
Lancet Infect Dis. 2020 Nov;20(11):1226-1227
pubmed: 32585134